Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy
- PMID: 30488829
- DOI: 10.4103/jcrt.JCRT_200_17
Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy
Abstract
Background: Parotid-sparing intensity-modulated radiotherapy (IMRT) effectively reduces xerostomia in head-and-neck cancer (HNC). Changes in the salivary output at 1 year were studied and correlation with quality of life (QOL) changes in patients of locally advanced HNC (LAHNC) was drawn.
Materials and methods: Between October 2009 and October 2011, 20 patients of LAHNC were treated with IMRT using simultaneous integrated boost technique. High-risk clinical target volume (CTV) was given a dose of 66 Gy/30 fr, intermediate-risk CTV 60 Gy/30 fr, and low-risk CTV 54 Gy/30 fr. The saliva flow rate was estimated for 5 min at rest (unstimulated) and after using lemon drops (stimulated) for the next 5 min, at baseline (pretreatment), and 3, 6, and 12 months following treatment. Evaluation of patients' perception of dry mouth was done using EORTC-QLQ-C30 and HN35 questionnaires at the same time points.
Results: Baseline unstimulated and stimulated salivary flow rates were 0.659 ml/min and 1.69 ml/min, respectively. At 3 months, a significant reduction in unstimulated (0.346 ml/min) and stimulated (0.80 ml/min) flow rate was observed. Unstimulated flow rate continued to decrease further till 6 months (0.295 ml/min), but slight improvement was seen in stimulated flow rate (0.91 ml/min). At 12 months, minimal recovery was observed in both unstimulated (0.362 ml/min) and stimulated flow rates (1.09 ml/min). EORTC-QOL questionnaire mean scores for dryness and stickiness of saliva were 10 and 15 at baseline and increased to 36 and 25, respectively, at 3 months. At 6 months, symptom score for dryness further increased to 45 and then decreased to 33 at 12 months. Stickiness score remained static from 3 to 12 months. Salivary flow rate correlated well with dry mouth (P < 0.05) but not with the perception of sticky saliva (P = 0.82) at 6 months and beyond.
Conclusions: Both salivary flow rate and xerostomia-related questions worsened at 3 months even with IMRT and showed a similar pattern of recovery.
Keywords: Head-and-neck cancer; intensity-modulated radiotherapy; xerostomia.
Conflict of interest statement
There are no conflicts of interest
Similar articles
-
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16. doi: 10.1016/s0360-3016(00)01441-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240231
-
Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1479-87. doi: 10.1016/j.ijrobp.2010.07.1990. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20934262
-
Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):663-73. doi: 10.1016/S0360-3016(03)01571-2. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967418 Clinical Trial.
-
Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.Expert Rev Anticancer Ther. 2015 Jan;15(1):109-19. doi: 10.1586/14737140.2015.961427. Epub 2014 Sep 18. Expert Rev Anticancer Ther. 2015. PMID: 25231774 Review.
-
Submandibular gland-sparing intensity-modulated radiotherapy.Am J Clin Oncol. 2014 Oct;37(5):514-6. doi: 10.1097/COC.0b013e318261054e. Am J Clin Oncol. 2014. PMID: 22892434 Review.
Cited by
-
Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.Support Care Cancer. 2021 Jan;29(1):127-134. doi: 10.1007/s00520-020-05454-5. Epub 2020 Apr 21. Support Care Cancer. 2021. PMID: 32318870
-
Quality of Life of Patients After Treatment for Cancer in the Head and Neck Region: A Case-Control Study.Cureus. 2022 Jun 9;14(6):e25800. doi: 10.7759/cureus.25800. eCollection 2022 Jun. Cureus. 2022. PMID: 35822149 Free PMC article.
-
Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study.PLoS One. 2019 Oct 2;14(10):e0223154. doi: 10.1371/journal.pone.0223154. eCollection 2019. PLoS One. 2019. PMID: 31577831 Free PMC article.
-
The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.Support Care Cancer. 2020 Feb;28(2):531-540. doi: 10.1007/s00520-019-04838-6. Epub 2019 May 10. Support Care Cancer. 2020. PMID: 31076897 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical